By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults.

With the rise of technology (and AI), decentralized clinical trials are becoming more popular where some or all of the ...

Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead ...

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...

Gifthealth has announced a strategic partnership with United Digestive, a leading practice management organization for ...

Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIA’s venture capital arm. This forms part of an expanded partnership to enhance Genesis’ AI-powered drug discovery platform, ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.

A recent Lindus Health survey emphasizes the importance of patient-centered designs in clinical trials, particularly ...

Pharmacokinetic (PK) tests form an integral part of the drug development process, helping to ensure the safety and efficacy of new drugs.